Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7DF8

full length hNPC1L1-Apo

Summary for 7DF8
Entry DOI10.2210/pdb7df8/pdb
EMDB information30662
DescriptorNPC1-like intracellular cholesterol transporter 1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
Functional Keywordscholesterol, membrane protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight144968.48
Authors
Hu, M.,Sun, S.,Sui, S. (deposition date: 2020-11-06, release date: 2021-08-04, Last modification date: 2024-10-30)
Primary citationHu, M.,Yang, F.,Huang, Y.,You, X.,Liu, D.,Sun, S.,Sui, S.F.
Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake.
Sci Adv, 7:-, 2021
Cited by
PubMed Abstract: Niemann-Pick C1-like 1 (NPC1L1) protein plays a central role in the intestinal cholesterol absorption and is the target of a drug, ezetimibe, which inhibits NPC1L1 to reduce cholesterol absorption. Here, we present cryo-electron microscopy structures of human NPC1L1 in apo state, cholesterol-enriched state, and ezetimibe-bound state to reveal molecular details of NPC1L1-mediated cholesterol uptake and ezetimibe inhibition. Comparison of these structures reveals that the sterol-sensing domain (SSD) could respond to the cholesterol level alteration by binding different number of cholesterol molecules. Upon increasing cholesterol level, SSD binds more cholesterol molecules, which, in turn, triggers the formation of a stable structural cluster in SSD, while binding of ezetimibe causes the deformation of the SSD and destroys the structural cluster, leading to the inhibition of NPC1L1 function. These results provide insights into mechanisms of NPC1L1 function and ezetimibe action and are of great significance for the development of new cholesterol absorption inhibitors.
PubMed: 34272236
DOI: 10.1126/sciadv.abg3188
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.03 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon